Patents by Inventor Diana LE

Diana LE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11813272
    Abstract: Disclosed herein are active agents, compositions containing them, unit dosage forms containing them, and methods of their use, e.g., for treating a metabolic disorder or nonalcoholic fatty liver disease or for modulating a metabolic marker or nonalcoholic fatty liver disease marker.
    Type: Grant
    Filed: November 17, 2020
    Date of Patent: November 14, 2023
    Assignee: Flagship Pioneering Innovations V, Inc.
    Inventors: Steven John Taylor, John Robert Proudfoot, Mi-Jeong Kim, Kathleen Nudel, Timothy F. Briggs, Afrand Kamali Sarvestani, Leonard Buckbinder, Bernard Lanter, Ferdinand Edward Massari, Koji Yasuda, Spencer Cory Peck, Cheri Snedeker, Diana Le, Jessica Alexander, Anna Liang, Dinara Gunasekera, David Arthur Berry, John Patrick Casey, Jr.
  • Publication number: 20210177877
    Abstract: Disclosed herein are active agents, compositions containing them, unit dosage forms containing them, and methods of their use, e.g., for treating a metabolic disorder or nonalcoholic fatty liver disease or for modulating a metabolic marker or nonalcoholic fatty liver disease marker.
    Type: Application
    Filed: November 17, 2020
    Publication date: June 17, 2021
    Inventors: Steven John TAYLOR, John Robert PROUDFOOT, Mi-Jeong KIM, Kathleen NUDEL, Timothy F. BRIGGS, Afrand KAMALI SARVESTANI, Leonard BUCKBINDER, Bernard LANTER, Ferdinand Edward MASSARI, Koji YASUDA, Spencer Cory PECK, Cheri SNEDEKER, Diana LE, Jessica ALEXANDER, Anna LIANG, Dinara GUNASEKERA, David Arthur BERRY, John Patrick CASEY, JR.
  • Patent number: 10953027
    Abstract: Disclosed herein are active agents, compositions containing them, unit dosage forms containing them, and methods of their use, e.g., for treating a metabolic disorder or nonalcoholic fatty liver disease or for modulating a metabolic marker or nonalcoholic fatty liver disease marker.
    Type: Grant
    Filed: February 27, 2020
    Date of Patent: March 23, 2021
    Assignee: Flagship Pioneering Innovations V, Inc.
    Inventors: Steven John Taylor, John Robert Proudfoot, Mi-Jeong Kim, Kathleen Nudel, Timothy F. Briggs, Afrand Kamali Sarvestani, Leonard Buckbinder, Bernard Lanter, Ferdinand Edward Massari, Koji Yasuda, Spencer Cory Peck, Cheri Snedeker, Diana Le, Jessica Alexander, Anna Liang, Dinara Gunasekera, David Arthur Berry, John Patrick Casey, Jr.
  • Publication number: 20200197428
    Abstract: Disclosed herein are active agents, compositions containing them, unit dosage forms containing them, and methods of their use, e.g., for treating a metabolic disorder or nonalcoholic fatty liver disease or for modulating a metabolic marker or nonalcoholic fatty liver disease marker.
    Type: Application
    Filed: February 27, 2020
    Publication date: June 25, 2020
    Inventors: Steven John TAYLOR, John Robert PROUDFOOT, Mi-Jeong KIM, Kathleen NUDEL, Timothy F. BRIGGS, Afrand KAMALI SARVESTANI, Leonard BUCKBINDER, Bernard LANTER, Ferdinand Edward MASSARI, Koji YASUDA, Spencer Cory PECK, Cheri SNEDEKER, Diana LE, Jessica ALEXANDER, Anna LIANG, Dinara GUNASEKERA, David Arthur BERRY, John Patrick CASEY, JR.
  • Publication number: 20040106121
    Abstract: The invention relates to an organized array of biological or chemical probes bonded to a support by magnetic coupling using a fixing vector. The support may include a permanent magnet or present electrically-induced magnetization. The fixing vectors may be constituted by magnetic beads functionalized to be capable of bonding specifically to one particular type of biological probe.
    Type: Application
    Filed: May 23, 2003
    Publication date: June 3, 2004
    Applicant: COMMISSARIAT A L'ENERGIE ATOMIQUE
    Inventors: Nicolas Ugolin, Gerard Marguerie De Rotrou, Thierry Kortulewski, Olivier Alibert, Diana Le Roux